Msd-Ertapenem 1 g Powder for injection
PDF Leaflet Revision Date: 18 July 2022
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of moderate to severe infections caused by susceptible bacteria.
Dosage (summary)
1 g once daily for adults; 15 mg/kg twice daily for children (max 1 g/day).
Special Populations
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Safety in pregnancy and breastfeeding not established.
Key Drug Interactions
- Valproic acid
- Divalproex sodium
Contraindications
- Hypersensitivity to beta-lactams
- Bacterial meningitis
- Severe shock
- Heart block
Common side effects
- Diarrhoea
- Nausea
- Headache
- Infused vein complication
Counselling Points
- Report any allergic reactions
- Monitor for signs of colitis
- Avoid mixing with other medications
Serious warnings
- Serious hypersensitivity reactions
- Seizures in predisposed patients
- Pseudomembranous colitis
Important Disclaimer
The Msd-Ertapenem 1 g Powder for injection professional information leaflet below is the property of Msd and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
